# Safety and Efficacy Study of Creatine and Tamoxifen in Volunteers With Amyotrophic Lateral Sclerosis (ALS)

> **NCT01257581** · PHASE2 · COMPLETED · sponsor: **Nazem Atassi** · enrollment: 60 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **DRUG:** creatine
- **DRUG:** tamoxifen

## Key facts

- **NCT ID:** NCT01257581
- **Lead sponsor:** Nazem Atassi
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2012-12
- **Final completion:** 2013-02
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2014-12-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01257581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01257581, "Safety and Efficacy Study of Creatine and Tamoxifen in Volunteers With Amyotrophic Lateral Sclerosis (ALS)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01257581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*